Ocrevus, the first drug for primary progressive multiple sclerosis approved by FDA
The FDA ( U.S. Food and Drug Administration ) has approved Ocrevus ( Ocrelizumab ) to treat adult patients with relapsing forms of multiple sclerosis and primary progressive multiple sclerosis ( PPMS ...
read article